| Literature DB >> 27226453 |
MacKenzie A Howard1, Scott C Baraban2.
Abstract
Interneuron-based cell transplantation is a powerful method to modify network function in a variety of neurological disorders, including epilepsy. Whether new interneurons integrate into native neural networks in a subtype-specific manner is not well understood, and the therapeutic mechanisms underlying interneuron-based cell therapy, including the role of synaptic inhibition, are debated. In this study, we tested subtype-specific integration of transplanted interneurons using acute cortical brain slices and visualized patch-clamp recordings to measure excitatory synaptic inputs, intrinsic properties, and inhibitory synaptic outputs. Fluorescently labeled progenitor cells from the embryonic medial ganglionic eminence (MGE) were used for transplantation. At 5 wk after transplantation, MGE-derived parvalbumin-positive (PV+) interneurons received excitatory synaptic inputs, exhibited mature interneuron firing properties, and made functional synaptic inhibitory connections to native pyramidal cells that were comparable to those of native PV+ interneurons. These findings demonstrate that MGE-derived PV+ interneurons functionally integrate into subtype-appropriate physiological niches within host networks following transplantation.Entities:
Keywords: cell therapy; interneuron; medial ganglionic eminence; neural transplant; synaptic integration
Mesh:
Substances:
Year: 2016 PMID: 27226453 PMCID: PMC4978788 DOI: 10.1152/jn.00321.2016
Source DB: PubMed Journal: J Neurophysiol ISSN: 0022-3077 Impact factor: 2.714